Health Care & Life Sciences » Pharmaceuticals | Miraca Holdings Inc.

Miraca Holdings Inc.

Miraca Holdings Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY111.9
Market Cap
JPY143.53 B
Shares Outstanding
57.36 M
Public Float
49.48 M

Profile

Address
Shinjuku Mitsui Building, 8/F
Tokyo Tokyo 163
Japan
Employees -
Website http://www.miraca-holdings.co.jp
Updated 07/08/2019
Miraca Holdings Inc. operates as a holding company which provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. It operates through the following segments: In Vitro Diagnostics, Clinical Laboratory Testing, and Healthcare Related. The In Vitro Diagnostic segment offers clinical laboratory testing services; collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back.

Financials

View All
Created with Highcharts 5.0.14Miraca Holdings Inc.Net Income. Fiscal year is April-March. All values JPY Millions.15 32215 32216 00216 0025 0815 0813333332572576 3866 38620142015201620172018201905k10k15k20k
Created with Highcharts 5.0.14Miraca Holdings Inc.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.203 371203 371204 667204 667211 743211 743204 245204 245195 400195 400181 415181 415201420152016201720182019050k100k150k200k250k

Shigekazu Takeuchi
President, Group CEO & Representative Director
Naoki Kitamura
Chief Financial Officer & Director